LyndaMVroomanMD

Pediatric Hematology & Oncology • Boston, MA

Instructor in Pediatrics, Boston Children's Hospital

Join to view full profile

Dr. Vrooman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Vrooman's full profile

Already have an account?

Office
Dana Farber Cancer Institution
44 Binney St
Boston, MA 02115
Phone+1 617-632-2659

Fax+1 617-582-8201

Education & Training

Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 2005 - 2008
Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 2002 - 2005
Harvard Medical SchoolClass of 2002

Certifications & Licensure

MA State Medical License 2008 - 2026
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy Start of enrollment: 2012 Nov 01
Completed
Phase 2
Bone Mineral Density Status in Pediatric and Adolescent Survivors of Childhood Cancer With History of Bone Fracture Start of enrollment: 2015 May 01
Recruiting
Roles: Principal Investigator, Contact

Publications & Presentations

PubMed

15 citations
Dexrazoxane and Long-Term Heart Function in Survivors of Childhood Cancer.
Eric J Chow, Sanjeev Aggarwal, David R Doody, Richard Aplenc, Saro H Armenian
Journal of Clinical Oncology. 2023-04-20
30 citations
Late health outcomes after dexrazoxane treatment: A report from the Children's Oncology Group.
Eric J. Chow, Richard Aplenc, Lynda M. Vrooman, David R. Doody, Yuan-Shung Huang
Cancer. 2021-10-13
10 citations
Effect of BMI on toxicities and survival among adolescents and young adults treated on DFCI Consortium ALL trials.
Shai Shimony, Yael Flamand, Yannis K Valtis, Andrew E Place, Lewis B Silverman
Blood Advances. 2023-09-26

Lectures

Efficacy and toxicity of pegaspargase and calaspargase pegol in childhood acute lymphoblastic leukemia/lymphoma: Results of DFCI 11-001.
2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

A Hard Push to Help Protect Survivors of Childhood CancerNovember 13th, 2018
After Cancer at 19, I Learned 'Chemo Brain' Can Last Long Past ChemoJanuary 12th, 2018
Postinduction Dexamethasone and Individualized Dosing of Asparaginase Improve Outcome in Pediatric ALLJune 10th, 2013
Join now to see all